Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein ۲ (MRP۲) inhibitors

  • سال انتشار: 1400
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 24، شماره: 6
  • کد COI اختصاصی: JR_IJBMS-24-6_013
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 231
دانلود فایل این مقاله

نویسندگان

Fatemeh Mosafa

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Farzin Hadizadeh

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Faezeh Fathi

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Eslami Nasab

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Tahereh Pourzahed

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Sayyed Mohammad Aboutorabzade

Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Razieh Ghodsi

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

چکیده

Objective(s): A new series of quinoline analogs of ketoprofen was designed and synthesized as multidrug resistance protein ۲ (MRP۲) inhibitors using ketoprofen as the lead compounds.Materials and Methods:  The cytotoxic activity of the compounds was evaluated againt two cancer cell lines including A۲۷۸۰/RCIS (MRP۲-overexpressing ovarian carcinoma), A۲۷۸۰, drug-sensitive ovarian carcinoma using MTT assay. Compounds showing low toxicity in MTT test were selected to investigate their MRP inhibition activity. MRP۲ inhibitory potency was evaluated by determination of the uptake amount of fluorescent ۵-carboxy fluorescein diacetate (۵-CFDA) substrate, by A۲۷۸۰/RCIS in the presence of the selected compounds. Mode of interaction between synthesized ligands and homology modeled MRP۲ was investigated by MOE software. Results: Compound ۶d, a ۴-carboxy quinoline possessing dimethoxy phenyl in position ۲ of quinoline ring, showed the most MRP۲ inhibition activity among all the quinolines and more than the reference drug ketoprofen. MRP۲ inhibition activity of compound ۷d was less in comparison to that of compound ۶d, indicating that carboxyl group in position ۴ of quinoline may interact with MRP۲.  Docking studies showed that compound ۷d methyl ester of ۶d, interacted less compared to its parent ۶d, which is consistent with biological results.Conclusion: This study indicates that ۶- or ۸-benzoyl-۲-arylquinoline is a suitable scaffold to design MRP۲ inhibitors. The position of benzoyl in quinoline ring is important in inhibition of MRP۲. Generally, MRP۲ inhibition activity of compound ۷d was less in comparison to that of ۶d, indicating that carboxyl group in position ۴ of quinoline may interact with MRP۲.

کلیدواژه ها

Anticancer, (ATP)-binding cassette, Multi-drug resistance protein, Multi-drug resistance protein inhibitor, Molecular docking, Quinoline, Synthesis

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.